NDC 50114-7041

Thyreoidea Compositum

Lactic Acid, L- And Viscum Album And Colchicum Autumnale Bulb And Conium Maculatum Flowering Top And Galium Aparine And Fucus Vesiculosus And Sedum Acre And Sempervivum Tectorum Leaf And Adenosine Tri

Thyreoidea Compositum is a Intradermal; Intramuscular; Intravenous; Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Heel Inc. The primary component is Lactic Acid, L-; Colchicum Autumnale Bulb; Conium Maculatum Flowering Top; Galium Aparine; Fucus Vesiculosus; Sedum Acre; Sempervivum Tectorum Leaf; Adenosine Triphosphate; Fumaric Acid; .alpha.-ketoglutaric Acid; Malic Acid; Sodium Diethyl Oxalacetate; Pulsatilla Vulgaris; Spongia Officinalis Skeleton, Roasted; Sus Scrofa Thyroid; Calcium Fluoride; Sus Scrofa Umbilical Cord; Pork Liver; Sus Scrofa Bone Marrow; Sus Scrofa Spleen; Sulfur; Sus Scrofa Thymus; Viscum Album Fruit; Cortisone Acetate.

Product ID50114-7041_b56ceb53-f812-40b1-967e-72a85d653e62
NDC50114-7041
Product TypeHuman Prescription Drug
Proprietary NameThyreoidea Compositum
Generic NameLactic Acid, L- And Viscum Album And Colchicum Autumnale Bulb And Conium Maculatum Flowering Top And Galium Aparine And Fucus Vesiculosus And Sedum Acre And Sempervivum Tectorum Leaf And Adenosine Tri
Dosage FormInjection
Route of AdministrationINTRADERMAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2011-07-08
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameHeel Inc
Substance NameLACTIC ACID, L-; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; GALIUM APARINE; FUCUS VESICULOSUS; SEDUM ACRE; SEMPERVIVUM TECTORUM LEAF; ADENOSINE TRIPHOSPHATE; FUMARIC ACID; .ALPHA.-KETOGLUTARIC ACID; MALIC ACID; SODIUM DIETHYL OXALACETATE; PULSATILLA VULGARIS; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA THYROID; CALCIUM FLUORIDE; SUS SCROFA UMBILICAL CORD; PORK LIVER; SUS SCROFA BONE MARROW; SUS SCROFA SPLEEN; SULFUR; SUS SCROFA THYMUS; VISCUM ALBUM FRUIT; CORTISONE ACETATE
Active Ingredient Strength3 [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 50114-7041-1

10 AMPULE in 1 CARTON (50114-7041-1) > 2.2 mL in 1 AMPULE
Marketing Start Date2011-07-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50114-7041-1 [50114704101]

Thyreoidea Compositum INJECTION
Marketing Categoryunapproved homeopathic
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-08
Inactivation Date2019-10-29

Drug Details

Active Ingredients

IngredientStrength
LACTIC ACID, L-3 [hp_X]/2.2mL

OpenFDA Data

SPL SET ID:9b2819ac-eb41-4a95-a53f-972498c66102
Manufacturer
UNII
UPC Code
  • 0350114704111
  • Pharmacological Class

    • Corticosteroid [EPC]
    • Corticosteroid Hormone Receptor Agonists [MoA]

    Trademark Results [Thyreoidea Compositum]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    THYREOIDEA COMPOSITUM
    THYREOIDEA COMPOSITUM
    86768871 not registered Dead/Abandoned
    Biologische Heilmittel Heel GmbH
    2015-09-25
    THYREOIDEA COMPOSITUM
    THYREOIDEA COMPOSITUM
    86509660 not registered Dead/Abandoned
    Biologische Heilmittel Heel GmbH
    2015-01-21
    THYREOIDEA COMPOSITUM
    THYREOIDEA COMPOSITUM
    74425455 1875015 Live/Registered
    Biologische Heilmittel Heel GmbH
    1993-08-17

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.